These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5483974)

  • 1. [Histochemical studies on fibrinolytic activity of experimental thrombi in rats after administration of direct and indirect fibrinolytic agents].
    Denk H; Fischer M
    Thromb Diath Haemorrh; 1970 Oct; 24(1):48-54. PubMed ID: 5483974
    [No Abstract]   [Full Text] [Related]  

  • 2. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.
    Hirsh J; Buchanan M; Glynn MF; Mustard JF
    J Lab Clin Med; 1968 Aug; 72(2):245-55. PubMed ID: 5671200
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood.
    Ishizu H; Nobuhara M; Takata H
    Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasoactive drugs and cerebral circulation].
    Pratesi F; Corsi C; Tesi M; Spinelli P; Brunetti S; Caramelli L
    Minerva Med; 1968 Dec; 59(96):5207-17. PubMed ID: 4974813
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolysis in vitro. II. Thrombolytic effect of streptokinase and urokinase in health and disease.
    Jacobsen CD; Chandler AB
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:225+. PubMed ID: 5862559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antirheumatics with fibrinolytic properties. Comparison between compounds of the flufenamic acid series with trifluoromethyl analogues of azapropazone].
    Wagner-Jauregg T; Jahn U; Bürlimann W
    Arzneimittelforschung; 1973 Jul; 23(7):911-3. PubMed ID: 4800442
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the quality and quantity of therapeutic (equal frontal, equal external) fibrinolysis in the thrombelastograph].
    Fischbacher W
    Klin Wochenschr; 1968 Sep; 46(18):1000-3. PubMed ID: 4235179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The behavior of plasmitic fibrinogenolytic and fibrinolytic activities after activation with streptokinase and urokinase].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1483-6. PubMed ID: 5878159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experimental studies on the thrombolytic effect of streptokinase].
    Markwardt F; Klöcking HP; Sedlarik K; Perlewitz J; Drawert J; Hoffmann J
    Acta Biol Med Ger; 1976; 35(2):193-203. PubMed ID: 998115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On intraocular fibrinolysis.
    Pandolfi M; Nilsson IM; Niléhn JE
    Thromb Diath Haemorrh; 1966 Jan; 15(1):161-72. PubMed ID: 5919798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.